Human immune cell engraftment does not alter development of severe acute Rift Valley fever in mice.
Rift Valley fever (RVF) in humans is usually mild, but, in a subset of cases, can progress to severe hepatic and neurological disease. Rodent models of RVF generally develop acute severe clinical disease. Here, we inoculated humanized NSG-SGM3 mice with Rift Valley fever virus (RVFV) to investigate...
Main Authors: | Jessica R Spengler, Anita K McElroy, Jessica R Harmon, JoAnn D Coleman-McCray, Stephen R Welch, James G Keck, Stuart T Nichol, Christina F Spiropoulou |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6054394?pdf=render |
Similar Items
-
Suboptimal Handling of Piccolo Samples or Reagent Discs for Consideration in Ebola Response
by: Jessica R. Spengler, et al.
Published: (2019-06-01) -
Fluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in Ifnar-/- mice.
by: Stephen R Welch, et al.
Published: (2019-12-01) -
Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model.
by: Kimberly A Dodd, et al.
Published: (2014-06-01) -
The Crimean-Congo Hemorrhagic Fever Virus NSm Protein Is Dispensable for Growth In Vitro and Disease in Ifnar<sup>-/-</sup> Mice
by: Stephen R. Welch, et al.
Published: (2020-05-01) -
Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice
by: Florine E. M. Scholte, et al.
Published: (2019-01-01)